Approximately half the population has experienced insomnia at some time in their lives. However, even of the 10% who have chronic insomnia, few choose to seek assistance. Most don’t realize that insomnia has several different classifications and can be treated through various behavioral and medical approaches.

Insomnia is usually considered a symptom rather than a disease or a diagnosis, and is defined as difficulty falling or staying asleep – or both – rather than by a specific number of hours spent sleeping. That’s because an individual’s sleep patterns are unique to them, and will vary across different ages and phases of their life.

Causes of insomnia may be medical, behavioral, situational, or psychological, and insomnia is typically categorized as transient (less than seven days), short-term (one to three weeks), or chronic (lasting longer than three weeks).

Artemis Institute for Clinical Research conducts clinical trials of investigative medications for the treatment of insomnia. Qualified individuals participating in a trial may be eligible to receive financial compensation for time and travel, study-related medical and psychological evaluations, and the investigative study medication at no cost.

If you are experiencing insomnia and would like to volunteer for a study, or if you know someone suffering from insomnia who may want to volunteer, please send us your request using the Join a Study form, or call us toll-free at 855-DoStudies (855.367.8834).

Application for Insomnia Clinical Research Study

Join Now!

Or Learn More About Another Study Area

Study Areas

Anemia
Binge Eating Disorder
Fibromyalgia
Alcohol & Drug Abuse
Allergies
Alzheimer's Disease
Anxiety Disorder
ADHD
Bipolar Disorder
Depression
Dermatology
Diabetes
Gastrointestinal Disorders
Hyperlipidemia
Hypertension
Infectious Disease
Insomnia & Sleep Disorder
Insomnia
Lower Back Pain
Migraine
Osteoarthritis
PTSD
Respiratory System
Schizophrenia
Women's Health
prev next

Contact Us

"*" Indicates Required Information
All information provided is confidential and will not be given or sold to any other agency without prior consent. Click here to view our Privacy Policy.